日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamics of natural selection preceding human viral epidemics and pandemics

人类病毒流行和大流行之前的自然选择动态

Havens, Jennifer L; Kosakovsky Pond, Sergei L; Zehr, Jordan D; Pekar, Jonathan E; Parker, Edyth; Worobey, Michael; Andersen, Kristian G; Wertheim, Joel O

A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer

一项随机II期临床试验,研究吉西他滨、白蛋白结合型紫杉醇、顺铂联合或不联合医疗监督下的生酮饮食治疗转移性胰腺癌患者的疗效。

Jameson, Gayle S; Roe, Denise J; Borazanci, Erkut; Hanna, Diana L; Roberts, Caroline G P; Pelster, Meredith S; Frank, Richard C; Alistar, Angela T; Miller, Alan M; Wiedmeier-Nutor, J Erin; Algaze, Sandra D; Zoller, Alison R; Hallberg, Sarah J; Wertheim, Betsy C; Lee, Keehoon; Cridebring, Derek; Rabinowitz, Joshua D; Gately, Stephen; Keppler, Jennifer; Sharma, Sunil; Von Hoff, Daniel D; Rasco, Drew W

Adherence of traffic-related particles to human red blood cells in vivo

交通相关颗粒物在人红细胞上的体内粘附

Grigg, Jonathan; Wertheim, David; Crust, Simon; Jeldes, Emanuel; Duffin, Rodger; Maher, Barbara A; Liu, Norrice M

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer

维莫非尼联合索拉非尼治疗KRAS突变晚期转移性胰腺癌的II期临床试验

Khawaja, Muhammad Rizwan; Jameson, Gayle; Cridebring, Derek; Shannon, Patricia; Han, Haiyong; Moore, Jaeger; Von Hoff, Daniel; Posner, Richard G; Hlavacek, William S; Kolch, Walter; Kholodenko, Boris N; Rukhlenko, Oleksii S; Roe, Denise J; Wertheim, Betsy C; Borazanci, Erkut

Synonymous substitution rate slowdown preceding the emergence of SARS-CoV-2 variants and during persistent infections

在SARS-CoV-2变异株出现之前以及持续感染期间,同义替换率会减缓。

Havens, Jennifer L; Gangavarapu, Karthik; Wang, Jade C; Taki, Faten; Luoma, Elizabeth; Pekar, Jonathan E; Amin, Helly; Lonardo, Steve Di; Omoregie, Enoma; Hughes, Scott; Andersen, Kristian G; Vasylyeva, Tetyana I; Suchard, Marc A; Wertheim, Joel O

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2

SARS-CoV 和 SARS-CoV-2 的祖先蝙蝠病毒的出现时间及其地理起源

Pekar, Jonathan E; Lytras, Spyros; Ghafari, Mahan; Magee, Andrew F; Parker, Edyth; Wang, Yu; Ji, Xiang; Havens, Jennifer L; Katzourakis, Aris; Vasylyeva, Tetyana I; Suchard, Marc A; Hughes, Alice C; Hughes, Joseph; Rambaut, Andrew; Robertson, David L; Dellicour, Simon; Worobey, Michael; Wertheim, Joel O; Lemey, Philippe

Genomic epidemiology of mpox virus during the 2022 outbreak in New York City

2022年纽约市痘痘疫情期间痘病毒的基因组流行病学

Akther, Saymon; Su, Michelle; Wang, Jade C; Amin, Helly; Taki, Faten; De La Cruz, Nelson; Chowdhury, Moinuddin; Clabby, Tyler; Kopping, Erik; Ruiz, Victoria E; Leelawong, Mindy; Latash, Julia; Johnson, Kimberly; Baumgartner, Jennifer; Wong, Marcia; Olsen, Aaron; Fowler, Randal C; Pekar, Jonathan E; Havens, Jennifer L; Vasylyeva, Tetyana I; Wertheim, Joel O; Hughes, Scott; Omoregie, Enoma

Leveraging genomic diagnostics for prognostics and therapeutics in pediatric acute leukemia

利用基因组诊断进行儿童急性白血病的预后和治疗

Newman, Haley; Wong, Derek; Wu, Jinhua; Schubert, Jeffrey; Golenberg, Netta; Naveh, Natali; Patel, Maha; Xu, Feng; Charles, Sarah; Chen, Jiani; Denenberg, Elizabeth H; Fanning, Elizabeth A; Gallo, Daniel; Luke, Tammy; Thomas, Morgan; Cao, Kajia; Chan, Ada J S; Holloman, Munashe; Fan, Zhiqian; Fu, Weixuan; Hunger, Stephen P; MacFarland, Suzanne P; Bernt, Kathrin M; Surrey, Lea F; Luo, Minjie; Wertheim, Gerald B; Li, Marilyn M; Tasian, Sarah K; Zhong, Yiming

DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition

DYRK1A抑制导致MYC和ERK激活,使KMT2A-R急性淋巴细胞白血病细胞对BCL2抑制敏感。

Ayyadevara, V S S Abhinav; Wertheim, Gerald; Gaur, Shikha; Chukinas, John A; Loftus, Joseph P; Lee, Sung June; Kumar, Anil; Swaminathan, Srividya; Bhansali, Rahul S; Childers, Wayne; Geng, Huimin; Milne, Thomas A; Hua, Xianxin; Bernt, Kathrin M; Besson, Thierry; Shi, Junwei; Crispino, John D; Carroll, Martin; Tasian, Sarah K; Hurtz, Christian

Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response

TP53突变型急性髓系白血病的化疗耐药性需要甲羟戊酸的副产物——香叶基香叶基焦磷酸——来诱导适应性应激反应。

Skuli, Sarah J; Bakayoko, A'ishah; Kruidenier, Marisa; Manning, Bryan; Pammer, Paige; Salimov, Akmal; Riley, Owen; Brake-Sillá, Gisela; Dopkin, Derrick; Bowman, Michael; Martinez-Gutierrez, Leslie N; Anderson, Colin C; Reisz, Julie A; Buono, Roberta; Paul, Madhuri; Saland, Estelle; Liccardo, Francesca; DeVine, Ann; Wong, Sarah; Xu, Jimmy P; Nee, Eva; Hausler, Ryan; Boettcher, Steffen; Sebti, Said M; Lai, Catherine; Maxwell, Kara N; Sarry, Jean-Emmanuel; Fruman, David A; D'Alessandro, Angelo; Mesaros, Clementina; Keith, Brian; Simon, M Celeste; Sung, Pamela J; Wertheim, Gerald; Skuli, Nicolas; Bowman, Robert L; Matthews, Andrew; Carroll, Martin